SCHEMBL7953803

SCHEMBL7953803

COc1[c]cccc1-c1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.46
MKNK2 Q9HBH9 2/20 0.46
CYP11B2 P19099 9/20 0.44
CYP11B1 P15538 8/20 0.44
CYP17A1 P05093 6/20 0.44
CYP19A1 P11511 4/20 0.44
CYP3A4 P08684 5/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP2A6 P11509 2/20 0.44
CYP1A2 P05177 2/20 0.44
PDE10A Q9Y233 1/20 0.43
POLB P06746 1/20 0.42
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2E1 P05181 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2B6 P20813 1/20 0.41
PTGS2 P35354 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720197 0.81 SMN1; SMN2 (0.38) CYP11B2CYP11B1KDM4ENPC1RAB9A
SCHEMBL4276321 0.81 PDE10A (0.43) MKNK1MKNK2CYP2A6PDE10APTGS2
SCHEMBL3535486 0.79 ALDH1A1 (0.39) CYP3A4ALDH1A1CYP2A6CYP1A2POLB
SCHEMBL8879482 0.78 CYP2A6 (0.49) CYP11B2CYP11B1CYP17A1CYP19A1CYP3A4
SCHEMBL7447711 0.76 ALDH1A1 (0.38) CYP19A1CYP3A4ALDH1A1POLBCYP2C19
SCHEMBL4279795 0.76 CYP2A6 (0.48) MKNK1MKNK2CYP19A1CYP2A6FYN
SCHEMBL23071560 0.76 CYP2A6 (0.50) MKNK1MKNK2CYP11B1CYP3A4ALDH1A1
SCHEMBL7952212 0.75 CYP2A6 (0.49) MKNK1MKNK2CYP11B2CYP11B1CYP17A1
SCHEMBL4365990 0.75 CYP2A6 (0.48) MKNK1MKNK2CYP11B2CYP11B1CYP17A1
SCHEMBL4288028 0.74 HSD17B1 (0.41) CYP3A4CYP2C9FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235758-B1 CENTRAL NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 2001-05-22 US disclosed
EP-0808312-B1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 2000-11-02 EP disclosed
US-5990133-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS SUCH AS ANXIETY OR DEPRESSION SMITHKLINE BEECHAM P.L.C. (GB) 1999-11-23 US disclosed